FR37M - New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin. - Google Patents
New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.Info
- Publication number
- FR37M FR37M FR832913A FR832913A FR37M FR 37 M FR37 M FR 37M FR 832913 A FR832913 A FR 832913A FR 832913 A FR832913 A FR 832913A FR 37 M FR37 M FR 37M
- Authority
- FR
- France
- Prior art keywords
- arthritic
- rheumatic
- treatment
- new drug
- inflammatory phenomena
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
- C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR827205A FR1363860A (en) | 1960-05-14 | 1960-05-14 | New corticosteroids and their preparation process |
Publications (1)
Publication Number | Publication Date |
---|---|
FR37M true FR37M (en) | 1960-11-28 |
Family
ID=8731411
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR827205A Expired FR1363860A (en) | 1960-05-14 | 1960-05-14 | New corticosteroids and their preparation process |
FR832913A Expired FR37M (en) | 1960-05-14 | 1960-07-13 | New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR827205A Expired FR1363860A (en) | 1960-05-14 | 1960-05-14 | New corticosteroids and their preparation process |
Country Status (2)
Country | Link |
---|---|
US (1) | US3161663A (en) |
FR (2) | FR1363860A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3354186A (en) * | 1961-05-02 | 1967-11-21 | Schering Ag | 16alpha-methyl-1, 4-pregnadiene-3, 20-diones |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH269976A (en) * | 1946-03-12 | 1950-07-31 | Organon Nv | Process for the production of ll-dehydro-corticosterone. |
GB710482A (en) * | 1947-09-11 | 1954-06-16 | Merck & Co Inc | Steroid compounds and processes for preparing them |
GB807227A (en) * | 1954-08-11 | 1959-01-14 | Schering Corp | Steroid campounds and processes for the manufacture thereof |
-
1960
- 1960-05-14 FR FR827205A patent/FR1363860A/en not_active Expired
- 1960-07-13 FR FR832913A patent/FR37M/en not_active Expired
-
1961
- 1961-05-03 US US124248A patent/US3161663A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR1363860A (en) | 1964-06-19 |
US3161663A (en) | 1964-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR37M (en) | New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin. | |
FR3244M (en) | New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin. | |
FR1187M (en) | New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin. | |
FR126M (en) | New drug, in particular for the treatment of postprandial or chronic hyperlipemia. | |
FR16M (en) | New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin. | |
FR1438M (en) | New drug effective in the treatment of atherosclerosis. | |
FR3316M (en) | New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin. | |
FR341M (en) | New tetrahydroxylated steroid drug, in particular for the treatment of spasms of coronary origin. | |
FR151M (en) | New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses. | |
FR186M (en) | New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin. | |
BE612141Q (en) | New drugs in particular for the treatment of spasms of coronary origin. | |
FR2929M (en) | Pharmaceutical composition for the treatment of arthritic and rheumatic conditions. | |
BE598672A (en) | Therapeutic composition for the treatment of hepatic disorders. | |
FR139M (en) | New drug for the treatment of migraines of hepatic origin and in general hepatic disorders. | |
FR1484M (en) | New drug in particular for the treatment of inflammatory manifestations of microbial origin. | |
FR1783M (en) | Stabilized forms of dimethylcarboxy-alkylsulfonium used, in particular, for the treatment of hepatic and vascular disorders. | |
FR3419M (en) | New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses. | |
FR1764M (en) | New drug in particular for the treatment of spasms of coronary or visceral origin. | |
FR1804M (en) | New drug in particular for the treatment of infections of microbial origin. | |
FR153M (en) | New isopropylated drug, in particular for the treatment of neurodepressive states and anxiety psychoses. | |
FR385M (en) | New drug for the treatment of staphylococcal infections and the like. | |
FR2603M (en) | New drug in particular for the treatment of hepatic degenerations of chemical, bacterial, toxic or senile origin. | |
FR1141M (en) | New drug in particular for the treatment of spasms of coronary origin. | |
FR1635M (en) | New drug in particular for the treatment of spasms of coronary origin. | |
FR133M (en) | New dihydroxy drug, in particular for the treatment of spasms of coronary origin. |